Results

Total Results: 904 records

Showing results for "author year description".

321. Technical Brief 16 Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/advanced-care-decision-aids_disposition-comments.pdf
     July 29, 2014 - three studies that were not identified for Making Your Wishes Known –two NIH awards (an ongoing 5-year … R-01 RCT and a completed R-23) and an American Cancer Society grant (for a 4-year RCT). … respects, this is a very nicely constructed technical brief that provides readers with an accurate description

322. autism-update-protocol-130920 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_research-protocol.pdf
     September 20, 2013 - participant characteristics (age, diagnosis, symptom severity, etc.), intervention characteristics (description … evidence table may vary by KQ as appropriate, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators … Autism after adolescence: population-based 13- to 22- year follow-up study of 120 individuals with autism

323. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/labor-nitrous-oxide_research-protocol.pdf
     August 24, 2011 - Disease Control and Prevention (CDC), more than 4 million births occur in the United States each year … These spreadsheets will allow each author to count key data points, such as study location, study type … vary by key question as appropriate, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … the ability to apply the intervention to other populations or other settings, such as inadequate description

324. Disposition of Comments Report for Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients Wtih Kidney Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
     August 11, 2014 - troponin assays (e.g., did study findings differ between those published early vs. late during the 23 year … We ran our meta-analysis figures in order by year to see if there was any evidence for a temporal difference … However, this is a highly valuable document that provides both detailed description and summaries of

325. Rapid Evidence Product: Misuse of ADHD Prescription Stimulants in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
     July 01, 2025 - Methods The section contains a summary of the project methods; Appendix A contains a full description … Spring 2022 Misuse with alcohol: very often 1%, often 7%, sometimes 15%. 11.2% response, no description … This report is made available to the public under the terms of a licensing agreement between the author … A-3 The following data was abstracted: • Study identifier (author) and publication year • Study … No 11.2%, no description of how managed C-10 Study ID Population ADHD Medications Mentioned

326. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
     January 01, 2020 - Adults tend to progressively gain weight through middle age.5 Although the average weight gained per year … • The study must report the change in weight over at least 1 year during adulthood. … □ We will include studies with any sample size from any year that meet all other criteria. … These studies adhered to the commonly held concepts of high quality, including the following: a clear description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

327. Abnormal-Uterine-Bleeding Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/abnormal-uterine-bleeding_research-protocol.pdf
     November 21, 2011 - PICOTS Criteria PICOTS Element Description Population: Nonpregnant women from menarche to menopause … (See Appendix B for the alternate text description.) … We will review these studies for evaluable data from patients meeting the description of the population … The evidence tables will contain common elements such as author, year of publication, study location … (e.g., city, state), enrollment period, population description, sample size, and study type (e.g.,

328. Research White Paper Registries in Accountable Care Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/accountable-care-registries-guide-3rd-ed-addendum-white-paper-2018-5.pdf
     January 01, 2018 - www.ahrq.gov Contract No. 290-2014-00004-C Prepared by: L&M Policy Research, LLC Washington, DC Author … ..................................... 2 v Registries in Accountable Care AUTHOR’S NOTE: The description … size, network configuration, operating model, and other characteristics, were current at the time the author … Types of accountable care arrangements Type of Accountable Care Arrangement Description Medicare … insurance companies. 2 Registries in Accountable Care Type of Accountable Care Arrangement Description

329. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_disposition-comments.pdf
     May 27, 2010 - Online: May 27, 2010 2 Comment Section Comment Response Introduction This section provided a description … Abstract No: LBA6006 Citation: J Clin Oncol 27:18s, 2009 (suppl; abstr LBA6006) Author … This would be particularly unfortunate as these under- 65 year old patients are those who stand to benefit … Both RTOG 0022 and 0225 have demonstrated preliminary survival (89-91% 2-year locoregional disease

330. Making Healthcare Safer IV: High Reliability Organization (HRO) as a Patient Safety Practice (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hro-protocol.pdf
     January 01, 2023 - efficiency Studies that do not report a primary outcome of interest Timing Evaluation at least a year … after beginning HRO implementation Less than a year after beginning HRO implementation Setting … Information will be organized according to the review questions, and will include author, year, study … outcomes, unintended consequences, implementation barriers and facilitators, required resources, and description

331. Registry of Patient Registries (RoPR) Policies and Procedures (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries_research-2012-2_1.pdf
     January 01, 2012 - ..........................10 Effective Health Care Program Research Report Number 41 v Author … Publishing a journal supplement to announce the initial registrants in the RoPR within the first year … period (e.g., 1 to 2 years), during which time they will attend in-person meetings (at least one per year … The RoPR record will require data elements such as registry classification, purpose, a brief description

332. Disposition of Comments Report for Screening, Behavioral Counseling, and Referral in Primary Care To Reduce Alcohol Misuse (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_disposition-comments.pdf
     July 10, 2012 - was by the authors of the report: “The findings and conclusions in this document are those of the author … Rubio); 1 probably used 10-15 minute interventions (Wallace—not reported in article, but email to author … We identified several studies with Knight J as the first author that did not meet our criteria as they … The SASQ and AUDIT at least identify current (past year) misuse. … We have also added description of additional studies that did support the findings.

333. Updating the Framework for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-framework-protocol.pdf
     September 06, 2023 - equity as a central feature of a framework Concept • Publications that include a figure or detailed description … Critical appraisal will focus on the source (e.g., published by an individual author group or endorsement

334. Breast-Cancer-Medications Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
     July 01, 2012 - Evidence Table Article ID, Author, year Trial n Subjects Primary Outcome Duration Study Quality … 1.05 (0.84- 1.31) -All-cause mortality: 1.00 (0.53-1.88) 33 Article ID, Author … 1.58 (1.19-2.10) -Nausea: 1.28 (1.01-1.60) -Arthritis: 1.26 (1.06-1.51) 34 Article ID, Author … , year Trial n Subjects Primary Outcome Duration Study Quality/ Applicability Findings Mean … Discontinuation rate for examestane was 32.8% compared to 28.7% for placebo. 35 Article ID, Author

335. chronic-fatigue-protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-fatigue_research-protocol.pdf
     May 01, 2014 - Studies to Answer the Key Questions Publication Date Range: Searches will begin in January 1988, the year … inclusion, data will be abstracted into categories that include but are not limited to: study design, year

336. Diabetes-Behavior-Programs Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_research-protocol.pdf
     June 05, 2014 - vs. >1 year); and, level of glycemic control (i.e., HbA1c <7 vs. ≥7 percent)? … ) versus longer (>1 year) times since diagnosis. … Author contact will be by email (to the corresponding author of each study), with a primary contact … To guide these discussions, TEP members will be given a list and description of components, delivery … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

337. Future Research Needs for Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers, Long-Term Effectiveness in All Ages, and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
     May 01, 2012 - The findings and conclusions in this document are those of the author(s), who are responsible for its … We provided potential stakeholders with a brief description of the project, including their role and … These materials included the executive summary of the draft review and a description of the FRN project … trial design; other study types would have sufficient issues with selection bias and intervention description … A 23-year comparison. J Abnorm Child Psychol 2003 Feb;31(1):1- 11. PMID: 12597695. 8.

338. Radiation Therapy for Bone Metastases (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/rt-bone-metatases-final-protocol-amendment.pdf
     August 10, 2022 - The Key Questions Provisional Key Questions, description of patients, interventions, comparators, … included studies will be abstracted into categories that include but are not limited to: study design, year … clinically and methodologically comparable studies.41,42 For NRSI, pooled estimates will be based on author-reported … Description of the strength of evidence grades Strength of Evidence Description High We are very … skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year

339. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide_executive.pdf
     April 01, 2007 - variables and/or construction of composite endpoints, statistical methods used for data analysis, and a description

340. Methods Guide for Medical Test Reviews Chapter 6 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
     July 01, 2012 - factors and, to the extent possible, using that clarity to guide study selection (inclusion/exclusion), description … in the review—whether through restricting key questions or from careful assessment, grouping, and description … • The final systematic review should include a description of the test’s use in usual practice and … Conflicts of interest: The author has no affiliations or financial involvement that conflicts with the … Corresponding author: Katherine E.